UNSPSC 51112202: Cyclophosphamide/mannitol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AN100. This VA Drug Class (AN100) classifies this compound as belonging to the group ANTINEOPLASTICS, ALKYLATING AGENTS.

UNSPSC 51112202 Cyclophosphamide/mannitol, a Commodity code, covers the procurement of this chemotherapy drug formulation by state and local health systems, correctional facilities, and public hospital networks. State and local governments purchase cyclophosphamide/mannitol primarily through their pharmacy departments and oncology programs to support cancer treatment protocols for eligible patient populations. The drug is typically acquired via standing orders, group purchasing organizations, or competitive bidding processes managed by state health departments or regional hospital purchasing cooperatives. Issuing bodies include state departments of corrections, public university hospital systems, county health departments, and municipal hospital authorities, though some procurement occurs through specialized GPO frameworks that aggregate demand across multiple jurisdictions.

The source provided contains no recent state and local contract opportunities tagged to this code and offers no geographic activity data, making it impossible to characterize current procurement concentration or representative recent solicitations. Without posted RFP, RFQ, IFB, or ITB records, the code appears inactive or sparse in the recent state and local procurement pipeline.